首页> 美国卫生研究院文献>World Journal of Gastroenterology >Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection

【2h】

Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection

机译：索非布韦和达卡他韦在治疗丙型肝炎病毒感染的肾移植患者中的疗效和安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

AIMTo assess the efficacy and safety of sofosbuvir and daclatasvir regimens for kidney transplantation (KT) patients with hepatitis C virus (HCV) infection.

机译：目的评估Sofosbuvir和daclatasvir方案对丙型肝炎病毒（HCV）感染的肾移植（KT）患者的疗效和安全性。

著录项

期刊名称 World Journal of Gastroenterology
作者
Yan Xue; Li-Xin Zhang; Lei Wang; Tao Li; Yun-Dong Qu; Feng Liu;
展开▼
作者单位

展开▼
年(卷),期 2017(23),32
年度 2017
页码 5969–5976
总页数 9
原文格式 PDF
正文语种
中图分类肠道病毒与肝炎病毒;肝及胆疾病;肠疾病;
关键词
Hepatitis C virus Sofosbuvir Daclatasvir Kidney transplantation Direct-acting antivirals;

机译：丙型肝炎病毒;Sofosbuvir;Daclatasvir;肾脏移植;直接作用抗病毒药;

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection [J] . Yan Xue, Li-Xin Zhang, Lei Wang, World Journal of Gastroenterology . 2017,第32期

机译：Sofosbuvir和daclatasvir在治疗丙型肝炎病毒感染的肾移植受者中的疗效和安全性
2. Safety and Efficacy of Sofosbuvir and Simeprevir Versus Sofosbuvir and Daclatasvir in Treatment of Na?ve Egyptian Patients with Chronic Hepatitis C Virus Infection [J] . Fathia Mohamed Abd EL Monem, Wafaa Mohamed ELZefzafy, Nessren Mohamed Bahaa EL Deen Mohamed, International Journal of Internal Medicine . 2018,第2期

机译：Sofosbuvir和Simeprevir相对于Sofosbuvir和Daclatasvir治疗初治的埃及慢性丙型肝炎病毒感染患者的安全性和有效性
3. Treatment of chronic hepatitis C viral infection with sofosbuvir and daclatasvir in kidney transplant recipients [J] . Huang Hongfeng, Tang Huanna, Deng Hao, Transplant infectious disease: an official journal of the Transplantation Society . 2019,第1期

机译：肾移植受者患者慢性丙型肝炎病毒感染治疗肾移植受者的慢性丙型肝炎病毒感染
4. Efficacy and Safety of Polymyxin B in the Treatment of Infections Caused by Multidrug- Resistant Gram-Negative Infections: A Retrospective Review [C] . Oh HML, Gan LH, Wee I International Congress of Chemotherapy and Infection . 2009

机译：多种抗革兰阴性感染治疗感染治疗感染的疗效和安全性：回顾性综述
5. The burden of parainfluenza virus infection in patients with hematological malignancy and hematopoietic stem cell transplant (HSCT) recipients in the absence of active immunization and approved therapy: The role of infection control. [D] . Hanmod, Santosh S. 2009

机译：在没有积极免疫和批准治疗的情况下，血液恶性肿瘤和造血干细胞移植（HSCT）患者的副流感病毒感染负担：感染控制的作用。
6. Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation [O] . Suresh Reddy, Raj Kumar Sharma, Sonia Mehrotra, 2018

机译：基于索非布韦的抗病毒治疗肾移植术后丙型肝炎病毒感染的疗效和安全性
7. Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection [O] . Yan Xue, Li-Xin Zhang, Lei Wang, 2017

机译：Sofosbuvir和Daclatasvir治疗肾移植受试者肝炎病毒感染的疗效和安全性

Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection

摘要

著录项

相似文献

相关主题

期刊订阅